Articles

Shares of Summit Therapeutics jumped more than 270% Thursday after the company said its experimental cancer drug outperformed Merck’s blockbuster Keytruda in a late-stage trial.

After dropping about 5% in Thursday’s regular session during a software-sector rout, Zscaler’s stock was surging 15% in the extended session.

Investors searching for more reasons to be cautious about the health of the software sector just got a big one.

Data-center end-market revenue rose 87% from a year before.

Shipments of AI servers more than doubled sequentially to $1.7 billion.

PagerDuty says a renewed focus on enterprise customers has helped stabilize growth despite general pressures in the software industry.

Buyers returned to the U.S. government-debt market on Thursday, following a two-day selloff in the longest-dated maturities that sent yields to one-month highs. It’s the type of buying interest that could keep Treasury yields in check from here.

Faraday Future shares were weighed down by the electric-vehicle startup’s full-year results this week.

Trump reportedly could tap Musk for an advisory role if the former president is re-elected.

A new human bird-flu case identified in a Michigan dairy worker is the first in the U.S. to involve acute respiratory symptoms, the Centers for Disease Control and Prevention said Thursday.

The youngest workers believe they’ll be able to retire earlier than previous generations. But earlier generations have run into problems — and so will they.

Hormel Foods, the parent of food brands including Skippy, Spam, Dinty Moore and La Victoria, beat fiscal second-quarter earnings expectations and raised its full-year outlook as profit margins improved, but fell short on sales.